Toxic Epidermal Necrolysis in a Patient with Allopurinol, Colchicine and Alcohol Use

被引:0
|
作者
Daye, Munise [1 ]
Temiz, Selami Aykut [2 ]
Arslan, Sevket [3 ]
Yosunkaya, Alper [4 ]
Gumus, Selim [1 ]
Uyanik, Orkun [5 ]
Nursen, Hayri Ahmet Burak [5 ]
机构
[1] Necmettin Erbakan Univ Meram, Tip Fak, Dermatol Ana Bilim Dali, Konya, Turkey
[2] Konya Eregli Devlet Hastanesi, Dermatol Klin, Konya, Turkey
[3] Necmettin Erbakan Univ Meram, Tip Fak, Ic Hastaliklari Ana Bilim Dalt, Immunol & Allerji Hastaliklari Ana Bilim Dali, Konya, Turkey
[4] Necmettin Erbakan Univ Meram, Tip Fak, Anesteziyol & Reanimasyon Ana Bilim Dali, Konya, Turkey
[5] Necmettin Erbakan Univ Meram, Tip Fak, Plast Rekonstruktif & Estetik Cerrahisi Ana Bilim, Konya, Turkey
来源
JOURNAL OF EMERGENCY MEDICINE CASE REPORTS | 2020年 / 11卷 / 03期
关键词
Toxic epidermal necrolysis; allopurinol; colchicine; intravenous immunoglobulin; STEVENS-JOHNSON-SYNDROME; INTRAVENOUS IMMUNOGLOBULIN;
D O I
10.33706/jemcr.684184
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Toxic epidermal necrolysis is a severe, acute, mucocutaneous, life-threatening hypersensitivity syndrome with high mortality and bullous lesions on the skin, eyes and mucous membranes. It often develops due to drugs. Sulfonamide group antibiotics and antiepileptic drugs are the most commonly responsible agents. Allopurinol is a common cause of toxic epidermal necrolysis as in most drug reactions. Colchicine is widely used in dermatology and rheumatology and is generally known as an agent with a broad safety profile. Case report: Here we present a case of toxic epidermal necrolysis in our case with allopurinol, colchicine and alcohol use in order to draw attention to the increased risk of drug coexistence. Conclusion: Again, we wanted to draw attention to the management of our case and the efficacy and safety of high-dose intravenous immunoglobulin therapy.
引用
收藏
页码:65 / 67
页数:3
相关论文
共 50 条
  • [21] The use of porcine xenografts in patients with toxic epidermal necrolysis
    Young, Jason B.
    Gondek, Stephen P.
    Troche, Maria
    Summitt, J. Blair
    Rae, Lisa
    Thayer, Wesley P.
    Kahn, Steven A.
    BURNS, 2016, 42 (08) : 1728 - 1733
  • [22] Severe toxic epidermal necrolysis precipitated by amphetamine use
    Roberts, H
    Chamberlain, A
    Rennick, G
    McLean, C
    Gin, D
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2006, 47 (02) : 114 - 116
  • [23] Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis): Historical considerations
    Roujeau, Jean-Claude
    DERMATOLOGICA SINICA, 2013, 31 (04) : 169 - 174
  • [24] Fatal Stevens-Johnson syndrome/toxic epidermal necrolysis induced by allopurinol-rituximab-bendamustine therapy
    Fallon, Michael J.
    Heck, Jessica N.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 21 (05) : 388 - 392
  • [25] Stevens Johnson syndrome and toxic epidermal necrolysis in Asian children
    Koh, Mark Jean-Aan
    Tay, Yong-Kwang
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (01) : 54 - 60
  • [26] Stevens-Johnson syndrome and toxic epidermal necrolysis in children
    Sotelo-Cruz, Norberto
    GACETA MEDICA DE MEXICO, 2012, 148 (03): : 265 - 275
  • [27] The management of toxic epidermal necrolysis
    Fernando, Suran L.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2012, 53 (03) : 165 - 171
  • [28] Intravenous immunoglobulin for treatment of toxic epidermal necrolysis
    Nasser, M
    Bitterman-Deutsch, O
    Nassar, F
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2005, 329 (02) : 95 - 98
  • [29] Use of etanercept to treat toxic epidermal necrolysis in a human immunodeficiency virus-positive patient
    Lee, Yung-Yi
    Ko, Jui-Hung
    Wei, Chia-Hung
    Chung, Wen-Hung
    DERMATOLOGICA SINICA, 2013, 31 (02) : 78 - 81
  • [30] Epidermal necrolysis (Stevens-Johnson syndrome and toxic epidermal necrolysis): Clinical manifestations and management
    Ingen-Housz-Oro, Saskia
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2023, 207 (07): : 917 - 923